Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
HEMO ORGANIC ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
HEMO ORGANIC Mar-23 |
ADCOCK INGRAM Jun-14 |
HEMO ORGANIC/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 79 | 325 | - | |
Low | Rs | 7 | 234 | - | |
Sales per share (Unadj.) | Rs | 0 | 96.6 | - | |
Earnings per share (Unadj.) | Rs | -0.2 | -24.3 | - | |
Cash flow per share (Unadj.) | Rs | -0.2 | -20.2 | - | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -0.1 | 75.8 | - | |
Shares outstanding (eoy) | m | 3.47 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3,122.2 | 2.9 | 107,909.1% | |
Avg P/E ratio | x | -270.9 | -11.5 | 2,359.0% | |
P/CF ratio (eoy) | x | -270.9 | -13.9 | 1,955.0% | |
Price / Book Value ratio | x | -289.4 | 3.7 | -7,849.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 148 | 47,183 | 0.3% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 0 | 2,961 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 3,798.6 | - | |
Avg. wages/employee | Rs Th | 0 | 689.8 | - | |
Avg. net profit/employee | Rs Th | 0 | -957.2 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 16,307 | 0.0% | |
Other income | Rs m | 0 | 114 | 0.0% | |
Total revenues | Rs m | 0 | 16,421 | 0.0% | |
Gross profit | Rs m | -1 | -2,826 | 0.0% | |
Depreciation | Rs m | 0 | 704 | 0.0% | |
Interest | Rs m | 0 | 442 | 0.0% | |
Profit before tax | Rs m | -1 | -3,857 | 0.0% | |
Minority Interest | Rs m | 0 | -11 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 241 | 0.0% | |
Profit after tax | Rs m | -1 | -4,109 | 0.0% | |
Gross profit margin | % | -1,092.0 | -17.3 | 6,301.4% | |
Effective tax rate | % | 0 | -6.2 | 0.0% | |
Net profit margin | % | -1,093.4 | -25.2 | 4,339.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 2 | 11,944 | 0.0% | |
Current liabilities | Rs m | 4 | 6,720 | 0.1% | |
Net working cap to sales | % | -3,172.0 | 32.0 | -9,902.3% | |
Current ratio | x | 0.6 | 1.8 | 31.6% | |
Inventory Days | Days | 0 | 111 | 0.0% | |
Debtors Days | Days | 4,319,629 | 124 | 3,485,270.6% | |
Net fixed assets | Rs m | 0 | 6,962 | 0.0% | |
Share capital | Rs m | 35 | 76 | 45.8% | |
Net worth | Rs m | -1 | 12,799 | -0.0% | |
Long term debt | Rs m | 0 | 4,498 | 0.0% | |
Total assets | Rs m | 2 | 24,179 | 0.0% | |
Interest coverage | x | 0 | -7.7 | - | |
Debt to equity ratio | x | -0.7 | 0.4 | -195.3% | |
Sales to assets ratio | x | 0 | 0.7 | 3.6% | |
Return on assets | % | -26.8 | -15.2 | 176.5% | |
Return on equity | % | 107.2 | -32.1 | -333.9% | |
Return on capital | % | 341.3 | -19.8 | -1,722.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1 | 1,392 | 0.1% | |
From Investments | Rs m | NA | -427 | -0.0% | |
From Financial Activity | Rs m | NA | 4,082 | 0.0% | |
Net Cashflow | Rs m | 1 | 5,047 | 0.0% |
Compare HEMO ORGANIC With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare HEMO ORGANIC With: ISTREET NETWORK LINK PHARMA GODAVARI DRU NUTRAPLUS PR ZENOTECH LABS
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.